Stanford University
Showing 12,351-12,400 of 13,057 Results
-
Jadene Wong
Clinical Professor, Pediatrics - Neonatology
Current Research and Scholarly Interests- Care of the Infant with Neonatal Opioid Withdrawal Syndrome (NOWS)
https://www.cpqcc.org/resources/neonatal-opioid-withdrawal-syndrome-nows-toolkit
https://nastoolkit.org/
https://podcasts.apple.com/us/podcast/episode-17-neonatal-abstinence-syndrome-dr-jadene-wong/id1581530231?i=1000558004429
- Primary Care for Preterm Infants and Children
https://www.cpqcc.org/preterm-primary-care-toolkit -
Ronald J. Wong
Sr Res Scientist-Basic Ls, Pediatrics - Neonatology
Current Role at StanfordSenior Research Scientist
-
Jennifer Woo, MD
Affiliate, Medicine - Med/Cardiovascular Medicine
BioDr. Woo is a board-certified, fellowship-trained cardiologist with the Adult Congenital Heart Program at Stanford Health Care. She is also a clinical assistant professor in the Divisions of Cardiovascular Medicine and Pediatric Cardiology at Stanford University School of Medicine.
She diagnoses and treats a range of cardiovascular diseases, with a focus on adult congenital heart disease. Dr. Woo has Level III training with the National Board of Echocardiography, a certification that recognizes her experience in complex cardiac imaging. She also has specialized expertise in cardiac MRI. Each of her patients receives a personalized, comprehensive care plan delivered with compassion.
Dr. Woo is heavily involved in adult congenital heart disease research. She has a particular interest in imaging and heart failure in adults with congenital heart disease. She has received grant funding for her work, including from the Adult Congenital Heart Association. The National Institutes of Health awarded granted her the Ruth L. Kirschstein National Research Service Award.
She has published research in several peer-reviewed journals, such as the Journal of the American College of Cardiology and Pediatric Cardiology. Dr. Woo has presented her findings at regional and national meetings, including the Adult Congenital Heart Disease Bay Area Conference and the International Symposium on Adult Congenital Heart Disease.
Dr. Woo is a member of the Adult Congenital Heart Association, American College of Cardiology, American Heart Association, and American Society of Echocardiography. -
Joseph Woo, MD, FACS, FACC, FAHA
Norman E. Shumway Professor, Professor of Cardiothoracic Surgery and, by courtesy, of Bioengineering
BioDr. Woo is a board-certified, fellowship-trained cardiothoracic surgeon, cardiovascular surgeon, and transplant surgeon with Stanford Health Care. He is professor and chair of the Stanford Medicine Department of Cardiothoracic Surgery and associate director of the Stanford Cardiovascular Institute. He is also the Norman E. Shumway Professor of Cardiothoracic Surgery and professor, by courtesy, in the Department of Bioengineering.
Dr. Woo is a nationally recognized surgeon, innovator, researcher, and educator in cardiothoracic surgery. He focuses on complex mitral and aortic valve repair, thoracic aortic surgery, heart and lung transplantation, and minimally invasive heart surgery. He was awarded the American Heart Association’s 2021 Clinical Research Prize for developing innovative and minimally invasive surgeries to repair and reconstruct heart valves.
In 2022, Dr. Woo and his team at Stanford Health Care performed the first beating-heart transplant from a donation after circulatory death (DCD) donor and organ perfusion system. Keeping a donor heart pumping while it’s transported to the recipient and then implanting the heart while it’s beating minimizes organ damage. This groundbreaking new procedure is expected to increase the number of hearts available for transplant while improving health outcomes.
As a physician-scientist, Dr. Woo has served as principal investigator on multiple studies funded by National Institutes of Health (NIH) grants. One explored an innovative therapy to stimulate vascular (blood-carrying) stem cells in the bone marrow and direct them to the heart to grow new blood vessels and improve blood flow to damaged heart muscle.
Dr. Woo has also been the primary investigator for clinical trials involving the administration of stem cells during coronary artery bypass grafting (CABG) and left ventricular assist device (LVAD) implantation. In addition, Dr. Woo has served as primary investigator for multiple clinical device trials. He has filed for and holds patents for several heart-related medical devices and surgical techniques.
Dr. Woo has co-authored more than 510 articles in peer-reviewed journals and has served as a reviewer for many of them, including the Annals of Thoracic Surgery, Journal of Thoracic and Cardiovascular Surgery, and Circulation. He has also presented his research and performed live surgery demonstrations both nationally and internationally.
Dr. Woo serves as president of the American Association for Thoracic Surgery (AATS) and past president of the AATS Cardiac Surgery Biology Club. He is a fellow of the American College of Surgeons, American College of Cardiology, and American Heart Association. He is a member of many other professional societies, including the World Society of Cardiovascular and Thoracic Surgeons and International Society for Heart Research. He also serves on the leadership committee of the American Heart Association’s Council on Cardiovascular Surgery and Anesthesia. -
Jennifer Woo Baidal
Associate Professor of Pediatrics (Gastroenterology) and, by courtesy, of Epidemiology and Population Health
BioJennifer Woo Baidal is Associate Professor of Pediatrics, with tenure, and Associate Chair for Clinical Research in the Department of Pediatrics at Stanford University School of Medicine. She is also Chair for the North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) Research Committee and a member of the American Academy of Pediatrics (AAP) Committee on Nutrition.
As the Principal Investigator for the Childhood Research in Obesity Prevention (CROP) lab, she has experience successfully obtaining funding through National Institutes of Health, PCORI, Robert Wood Johnson Foundation, and Doris Duke Foundation to lead action-oriented child health research. Dr. Woo Baidal’s health services research program aims to improve health for all children, with a focus on reducing childhood obesity. Her research program translates clinical, community, and epidemiologic findings into population-level interventions during pregnancy, infancy, and early childhood to reduce food insecurity, improve nutrition, and prevent childhood obesity and related chronic diseases. She has shown the vital role of early life factors on chronic disease prevention, including the promise of 'food as prevention' for infants in households with food insecurity. Her work has been featured by the New York Times, NPR, and CNN, and cited in AAP guidelines and by the National Academies of Science and Medicine. In 2023, she was honored with the AAP's Mitchell B Cohen Early to Mid-Career Leadership Award. -
Douglas Wood
Affiliate, Technology & Digital Solutions
Current Role at StanfordWorking within the School of Medicine, I am developing solutions for the Stanford Bone Marrow Transplant, Lymphoma, and Cancer Institute Research Databases
My Stanford Projects:
- Stanford Cancer Center Research Database (SCIRDB)
Developed a web-based platform to integrate data from the Stanford Cancer Institute (EPIC/Clarity), Stanford Tumor Registry, STRIDE (Tissue Bank & Pre-EPIC Data), and several other systems into a "one-stop shop" for data analysis and annotation by cancer researchers. This cohort-driven system allows users to focus on their patients of interest and provides free-text search of all their notes, reports and narratives as well as a timeline-based view of all events for a patient. Easy exports allow for data analysis in biostatistical tools and the system can perform complex analysis using the open-source R statistical software as a service.
- Lymphoma Program Project (LPP)
Rearchitected an existing legacy database system that tracks Stanford's Non-Hodgkins and Hodgkins Lymphoma cases back to the late 1960's. Enables clinicians to track diagnosis, courses of treatment, long-term follow-up, and clinical responses to the diseases.
- Bone Marrow Transplant Program
Developed replacement web-enabled database based on legacy system in place since 1980s that enhanced data capture abilities by leveraging data feeds from BMT Clinic and Stanford Hospital. Also enabled electronic form submission to national transplant databank via XML-based web-services.
- Transplant Arteriosclerosis, Viral and Host Mechanisms
Developed web-based application and reporting systems Gathered requirements, translated requirements into technical specifications, built reporting tools, designed table schemas, migrated database tables from Access to Oracle, normalizing and validating data in the process. Wrote all SQL scripts for automating data migration.
- Stanford Asian Pacific Program in Hypertension and Insulin Resistance (SAPPHIRe)
Provided on-going maintenance for the project by uploading data, generating reports for statistical analysis and modifying table schema to incorporate new measurements such as creatinine.
- GenePad Project
Developed a web-based tool for quality assurance of scanned form data that allows users to view scanned input and validate it before storing it into final database tables. The tool dynamically configures itself by examining the structure of the database. -
Helen J. Wood
Affiliate, Psychiatry and Behavioral Sciences
BioDr. Helen Wood (she/her) is a clinical psychologist licensed in Vermont and Pennsylvania. She works for INSPIRE training and is also a Clinical Associate Professor at the University of Vermont, Department of Psychological Science. Dr. Wood was previously the psychologist for outpatient psychosis services, including a first-episode psychosis service, at an academic medical center in southwest Pennsylvania, where she led CBTp implementation. She has worked as program director for an adult psychosis inpatient unit, as well as in outpatient services in the US and in the UK’s National Health Service. She co-chairs the North American CBTp Network’s early psychosis working group. Dr. Wood values collaboration with people bringing lived experience knowledge to clinical, training, and research contexts. Dr. Wood’s clinical and research interests focus on understanding the experience of psychosis and improving services and/or other forms of support. Dr. Wood has a BA Hons in History, Theology and Religious Studies from the University of Cambridge, an MSc in Experimental Psychology from the University of Sussex, and a Doctorate in Clinical Psychology from Canterbury Christ Church University, all in the UK.
-
Tracey Woodruff
Professor of Epidemiology and Population Health and Senior Fellow at the Woods Institute for the Environment
BioMy research is devoted to identify and addressing environmental pollution exposures - petrochemicals, pesticides, plastics and other toxic contaminants - and the impacts on health. I focus on filling critical gaps in knowledge that will result in structural changes that improve health and reduce inequities. I collaborate across disciplines to create systemic solutions that integrate environmental health, public policy, and healthcare for significant public health advancements. My research expertise encompasses all aspects of understanding and characterizing environmental chemical exposures and their health impacts, especially on vulnerable and susceptible populations due to life stage, such as pregnant women and children, and demographics, such as poverty and race/ethnicity. I led multidisciplinary investigations to: identify and measure human exposures to environmental contaminants via modeling and biomonitoring including advanced methods for nontargeted analysis; identify biological mechanisms using in vitro and in vivo systems; assess the impact of multiple chemical exposures on pregnancy and child outcomes via epidemiology studies; and develop and apply methods for translating research findings into improved clinical care and public policy.
I have extensive expertise and experience in translating science into clinical and policy decision-making. I led the development of the Navigation Guide Systematic Review Methodology, the first systematic review method for environmental health science, developed in collaboration with multiple collaborators from international, national, and state governments, community groups, and the clinical community, integrates best practices from clinical medicine and environmental health evaluation. I continue to collaborate on systematic reviews including pesticides and Parkinson’s, and methodological improvements. I am widely recognized for my expertise in the use of science in decision making for environmental chemicals. I’ve been invited to testify before Congress and the State of California multiple times and I lead our Science Action Network that engages in bring best available science to regulatory decision-making. I have also collaborated with other faculty on empirical research to identify how industries adversely influence the scientific process.
Before Stanford, I was a Professor at UCSF and Director of the Program on Reproductive Health and the Environment. I now with UCSF co-lead the UCSF/Stanford Environmental Research and Translation for Health Center funded by a NIEHS P30 mechanism. Prior to UCSF I served for over 10 years in the Office of Policy at the US Environmental Protection Agency. -
Emily Woods
Postdoctoral Scholar, Pathology
Current Research and Scholarly Interestsdevelopment of activity-based probes for specific diagnosis and treatment of Staphylococcus aureus infections and for detection of bacterial ear infections (otitis media)
